The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.

 

To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

 

The USD 6+ billion (by 2030) financial opportunity associated with nuclear medicine and radiopharmaceuticals manufacturing, has been analyzed across the following segments:

  • Target Disease Indication 
  • Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Lupus Nephritis
  • Melanoma
  • Multiple Myeloma
  • Primary Sjögren's Syndrome
  • Others 

 

  • Target Immune Checkpoint
  • B7-H3
  • CD38
  • CD40
  • CD47
  • Others

 

  • Mechanism of Action
  • Inhibitory
  • Stimulatory

 

  • Therapeutic Modality
  • Monoclonal Antibody
  • Small Molecule

 

  • Type of Therapy 
  • Monotherapy 
  • Combination Therapy

 

  • Route of Administration
  • Intravenous
  • Subcutaneous
  • Others

 

  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific and the Rest of the World 

 

The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • Advanced Accelerator Applications
  • Belgian Nuclear Research Center (SCK•CEN)
  • Cardinal Health
  • China Isotope & Radiation Corporation
  • Curium Pharma
  • DuChemBio
  • Eckert & Ziegler
  • Eczacibasi-Monrol
  • GE Healthcare
  • Jubilant DraxImage
  • Lantheus Medical Imaging
  • Nihon Medi-Physics
  • Nordion
  • PETNET Solutions
  • SinoTau Pharmaceuticals
  • SOFIE

 

To request for sample report  -  https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing/request-sample.html

 

Table of Contents

 

  1. Preface

    2. Executive Summary

  2. Introduction

  3. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape

  4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape

  5. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America

  6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe

  7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World

  8. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Competitiveness Analysis

  9. Partnerships and Collaborations

  10. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)

  11. Market Forecast and Opportunity Analysis

  12. Concluding Remarks

 

  1. Executive Insights

 

  1. Appendix 1: Tabulated Data

 

  1. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

 

You may also be interested in the following titles:

  1. High Energy Chemistry / Hazardous Chemistry-based API Manufacturing Services Market: Focus on High Temperature, Low Temperature / Cryogenic, High Pressure and Low Pressure Chemistries, 2020-2030
  2. Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030
  3. China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030
  4. Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis